Trial intelligence / Profile preview

Betamethasone Microsphere (DE-102) in Macular Edema Following BRVO

NCT01512901Phase 3Completed

Sponsor
Santen Pharmaceutical
Modality
Orthosteric Ligands
Countries
2
01

Overview

A Phase 3 trial of betamethasone in macular edema, sponsored by Santen Pharmaceutical. Status: completed.

02

Drugs

betamethasone
03

Conditions

macular edema

Beyond the preview

Go deeper on NCT01512901.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01512901.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call